Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)
NCT03131726
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Graves Ophthalmopathy
Thyroid Associated Ophthalmopathy
Thyroid Associated Orbitopathy
Interventions
DRUG:
Simvastatin 40mg
Sponsor
Lund University
Collaborators
[object Object]